SANUWAVE Health, Inc. SNWV
Medical/Dental Instruments · data as of November 13, 2026
SANUWAVE Health, Inc. (SNWV) is a healthcare company listed in the US with a market value of about $16M. In the twelve months to September 30, 2026 it had revenue of $41M and net income of $4M, a net margin of 10.1%.
Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is value (4/5); the weakest is shareholder returns (0/5).
Key numbers: a P/E of 3.8, a price to free cash flow of 6.0, 5-year revenue growth of 61% a year, a 5-year average ROIC of 20%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 334% above the current price.
About SANUWAVE Health
SANUWAVE Health is listed in the US and classified in medical/dental instruments. Revenue went from $738527 in 2017 to $44M in 2025, growth of about 66.7% a year. It was profitable in 1 of the last 9 years in our data. Its share count rose by 520% over three years (dilution for shareholders). It spends 3% of revenue on research and development.
Score: 2.6 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
Checks not passed
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
- Debt below 3 years of free cash flow
- Liabilities below 60% of assets
- Pays a dividend
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $44M | $33M | $20M | $17M | $13M | $4M | $2M | $2M | $738527 |
| Net income | $4M | $12M | -$33M | -$26M | -$10M | -$27M | -$31M | -$10M | -$12M | -$6M |
| Free cash flow | $3M | $2M | $2M | -$5M | -$18M | -$7M | -$13M | -$6M | -$4M | -$2M |
| EPS (diluted) | $0.48 | $1.23 | $-7.41 | $-12.19 | $-7.50 | $-18.75 | $-30.00 | $-18.75 | $-30.00 | $-15.00 |
| Net margin | 10.1% | 26.8% | -101.4% | -126.5% | -61.5% | -209.5% | -762.6% | -682.3% | -628.7% | -749.9% |
| ROIC | — | 20.0% | — | — | — | — | -579.9% | — | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is SANUWAVE Health’s P/E ratio?
About 3.8, based on the last twelve months of diluted earnings per share.
Is SANUWAVE Health stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 334% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does SANUWAVE Health pay a dividend?
Not currently.
Is SANUWAVE Health a good stock to buy?
We do not give buy or sell advice. SANUWAVE Health scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.